Cargando…
Dissecting the Methylomes of EGFR-Amplified Glioblastoma Reveals Altered DNA Replication and Packaging, and Chromatin and Gene Silencing Pathways
SIMPLE SUMMARY: Glioblastoma is the most malignant brain tumor. To date, there is no curative therapy available. Since EGFR is an interesting candidate in precision medicine, we performed an integrated molecular analysis in glioblastoma with and without EGFR amplification. We found that there are si...
Autores principales: | Kraus, Theo F. J., Langwieder, Celina K., Hölzl, Dorothee, Hutarew, Georg, Schlicker, Hans U., Alinger-Scharinger, Beate, Schwartz, Christoph, Sotlar, Karl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341082/ https://www.ncbi.nlm.nih.gov/pubmed/37444635 http://dx.doi.org/10.3390/cancers15133525 |
Ejemplares similares
-
Methylome Profiling of PD-L1-Expressing Glioblastomas Shows Enrichment of Post-Transcriptional and RNA-Associated Gene Regulation
por: Hutarew, Georg, et al.
Publicado: (2022) -
EGFR Amplification Is a Phenomenon of IDH Wildtype and TERT Mutated High-Grade Glioma: An Integrated Analysis Using Fluorescence In Situ Hybridization and DNA Methylome Profiling
por: Hölzl, Dorothee, et al.
Publicado: (2022) -
Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma
por: Hölzl, Dorothee, et al.
Publicado: (2021) -
A patient with two gliomas with independent oligodendroglioma and glioblastoma biology proved by DNA-methylation profiling: a case report and review of the literature
por: Kraus, Theo F. J., et al.
Publicado: (2022) -
Alterations in 3D chromatin organization contribute to tumorigenesis of EGFR-amplified glioblastoma
por: Yang, Qi, et al.
Publicado: (2022)